Enrich in the USA
Glycanostics, Ltd. is one of the three winners of the ENRICH in the USA (European Network of Research and Innovation Centres and Hubs) funding summit – Slovakia day. We are looking
ISO 9001:2015 Certificate
We have been awarded the ISO 9001:2015 certificate in Research and Development of In-vitro Diagnostics Medical Devices.
EIC Accelerator Awareness Event Czech Republic and Slovakia
You could meet us once again at the EIC Accelerator Awareness Event for Czech Republic and Slovakia, which took place in Brno, Czech Republic, on 11 July 2022. Our CEO
Life Saving Ideas
Tests developed by the innovative Slovak company Glycanostics bring hope and solutions for the early non-invasive diagnosis of prostate cancer and 10 other types of cancer. With an accuracy of
EU Finance Day for Businesses
Our CEO Eva Kovacova presented Glycanostic’s success story as well as learnings and experience with the EIC Accelerator scheme during the EU Finance Day for Businesses organized by the European
EU Workshop on Innovation and Technology Transfer in Central and Southeast Europe
Our CEO Eva Kovacova was invited to present at the workshop organized by JRC’s Competence Centre on Technology Transfer that brought together key stakeholders of the innovation ecosystem in Central
European Women founders group
Our CEO Eva Kovacova was invited by EU Commissioner Mariya Gabriel to a meeting in Sofia, to launch the first European Women founders group consisting of two outstanding women company
Regional seminar of pneumologists
Our CSO Ján Tkáč was invited to give a presentation at the Regional seminar of pneumologists that brought together pneumologists from the Bratislava region. We shared our approach, which can
LSX World Congress 2022
After a long break due to COVID pandemic, we attended an in-person Life Science Executive Leaders (LSX) conference on May 10th and 11th in London. We presented our break-through innovation
New, highly experienced team members with a lot of passion, enthusiasm and drive have joined our growing Glycanostics team
We are happy to announce that our team is growing. Warm welcome to our R&D, marketing, business development, HR and office admin team members! We are looking forward to build
We feel privileged to have been accepted as a member of the Oslo Cancer Cluster
Glycanostics has become a member of the Oslo Cancer Cluster (OCC), an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of
Glycanostics have been awarded a Seal of Excellence under the EIC Transition scheme to continue with its development of diagnostic tests for breast, lung and pancreatic cancers
Applications that meet all the criteria but are not recommended for funding due to budget limitations will be awarded a Seal of Excellence to help them secure funding from other
